Roger Sawhney - 12 Aug 2024 Form 4 Insider Report for ACTUATE THERAPEUTICS, INC. (ACTU)

Reporting relationship: Director
Issuer ticker: ACTU
Reported as of: 12 Aug 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Aug 2024, 19:25:49 UTC
Prior SEC filing: 01 Mar 2023
Next SEC filing: 23 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Paul Lytle, Attorney-in-Fact

Key filing fact

Roger Sawhney filed Form 4 for ACTUATE THERAPEUTICS, INC. (ACTU) on 14 Aug 2024.

Key facts

This page summarizes Roger Sawhney's Form 4 filing for ACTUATE THERAPEUTICS, INC. (ACTU).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 14 Aug 2024, 19:25.

Change

Previous filing in this sequence was filed on 01 Mar 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ACTU transaction Derivative

Non-Qualified Stock Options

Award

Transaction value: $0
Shares: +30,000
Change %
Price: $0.000000
Shares after: 30,000
Date: 12 Aug 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 30,000
Exercise price: $8.00
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

30,000 stock options granted upon the effectiveness of the registration statement for the issuer's initial public offering on August 12, 2024, which vest in three equal installments on the first, second, and third anniversary of the grant date, subject to the reporting person's continued service through each such vesting date.